Effects of the Hippo Signaling Pathway in Human Gastric Cancer
Authors:
- Xiao-Yu LiXLXiao-Yu Li
- Qi ZhangQZQi Zhang
- Kun ZhaoKZKun Zhao
- Cui-Ping ZhangCui-Ping Zhang
- Chang-Hu XueCXChang-Hu Xue
- Kun YangKYKun Yang
- Zi-Bin TianZTZi-Bin Tian
Open Access
- 30 September 2013
- journal article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 14 (9) , 5199-5205
Abstract
The Hippo signaling pathway is a newly discovered and conserved signaling cascade, which regulates organ size control by governing cell proliferation and apoptosis. This study aimed to investigate its effects in human gastric cancer. Tumor tissues (n=60), adjacent non-tumor tissues (n=60) and normal tissues (n=60) were obtained from the same patients with primary gastric cancer (GC). In addition, 70 samples of chronic atrophic gastritis (CAG) tissues were obtained from patients with intestinal metaplasia (IM) by endoscopic biopsy. Hippo signaling molecules, including Mst1, Lats1, YAP1, TAZ, TEAD1, Oct4 and CDX2, were determined by quantitative polymerase chain reaction (qPCR). Protein expression of Mst1, Lats1, YAP1, TEAD1 and CDX2 was assessed by immunohistochemistry and Western blotting. Mst1, Lats1 and Oct4 mRNA expression showed an increasing tendency from GC tissues to normal gastric tissues, while the mRNA expression of YAP1, TAZ and TEAD1 was up-regulated (all P<0.01). Mst1 and Lats1 protein expression presented a similar trend with their mRNA expression. In addition, YAP1 and TEAD1 protein expression in GC was significantly higher than in the other groups (all P<0.01). CDX2 mRNA and protein expression in the CAG group were higher than in the other groups (all P<0.01). In GC, mRNA expression of Mst1, Lats1, Oct4, YAP1, TAZ, TEAD1 and CDX2 had a close correlation with lymphatic metastasis and tumor TNM stage (all P<0.01). Furthermore, protein expression of Mst1, Lats1 ,YAP1, TAZ, TEAD1 and CDX2 had a close correlation between each other (P<0.05). The Hippo signaling pathway is involved in the development, progression and metastasis of human gastric cancer. Therefore, manipulation of Hippo signaling molecules may be a potential therapeutic strategy for gastric cancer.Keywords
This publication has 21 references indexed in Scilit:
- CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancerCancer Biology & Therapy, 2012
- Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric CarcinomaJournal of Surgical Research, 2012
- CDX1 and CDX2 Expression in Intestinal Metaplasia, Dysplasia and Gastric CancerJournal of Korean Medical Science, 2011
- CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotypeGut, 2010
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- Pathogenesis of Barrett's esophagus: Bile acids inhibit the Notch signaling pathway with induction of CDX2 gene expression in human esophageal cellsSurgery, 2009
- The Hippo Signaling Pathway Components Lats and Yap Pattern Tead4 Activity to Distinguish Mouse Trophectoderm from Inner Cell MassDevelopmental Cell, 2009
- Gastric and Intestinal Phenotypic Marker Expression in Early Differentiated-Type Tumors of the Stomach: Clinicopathologic Significance and Genetic BackgroundClinical Cancer Research, 2006
- The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes ApoptosisCell, 2003
- The Cdx-1 and Cdx-2 homeobox genes in the intestineBiochemistry and Cell Biology, 1998